Quarterly Net Margin
-258.89%
+386.69%+59.90%
30 September 2024
Summary:
Monte Rosa Therapeutics quarterly net profit margin is currently -258.89%, with the most recent change of +386.69% (+59.90%) on 30 September 2024. GLUE quarterly net margin is now at all-time high.GLUE Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLUE Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
GLUE Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +91.4% | ||
| 5 y | 5 years | at high | +91.4% | ||
| alltime | all time | at high | +91.4% |
Monte Rosa Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -258.89%(-59.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -645.58%(-78.5%) |
| Mar 2024 | - | -3004.51% |
FAQ
- What is Monte Rosa Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Monte Rosa Therapeutics?
What is Monte Rosa Therapeutics quarterly net profit margin?
The current quarterly net margin of GLUE is -258.89%
What is the all time high quarterly net margin for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly net profit margin is -258.89%